NCT04157010View on ClinicalTrials.gov

Tocilizumab REMission in Early RA

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

March 29, 2016

Study Completion Date

March 29, 2016

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Tocilizumab

DRUG

Methotrexate

Trial Locations (1)

LS7 4SA

Leeds Teaching Hospitals NHS Trust, Leeds

All Listed Sponsors
collaborator

Hoffmann-La Roche

INDUSTRY

lead

University of Leeds

OTHER

NCT04157010 - Tocilizumab REMission in Early RA | Biotech Hunter | Biotech Hunter